We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5406:TSEKobe Steel, Ltd. Analysis

Data as of 2026-06-12 - not real-time

¥1,947.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kobe Steel is trading just above its 20‑day and 50‑day SMAs (≈ 1,935 JPY) at 1,947 JPY, with a neutral RSI of 51.5 but a bearish MACD (line –7.25 vs signal –4.29) and decreasing volume, indicating short‑term pressure. The price sits between a support level of 1,857 JPY and resistance at 2,018.5 JPY, giving a modest upside of about 4 % while volatility remains elevated at 27 % over the past 30 days.
Fundamentally, the stock appears cheap on traditional value metrics (PE ≈ 8.2×, PB ≈ 0.61×) and offers an attractive dividend yield of 4.21 % with a sustainable payout ratio of 33 %. However, revenue is contracting (‑1.9 % YoY), margins are thin (gross 16.5 %, operating 5 %), and leverage is high (debt‑to‑equity ≈ 58 %). A DCF model places fair value near 917 JPY, implying the market may be overvalued despite the “extreme greed” sentiment (fear‑greed index 86.7). Recent news of an expected earnings decline for H1 further tempers enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume suggest limited upside
  • Support at 1,857 JPY provides a floor but upside is modest
  • H1 earnings decline forecast adds downside pressure

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Low valuation multiples (PE ≈ 8×, PB ≈ 0.6×) offer some margin of safety
  • High dividend yield and sustainable payout support total return
  • Weak revenue growth and high leverage keep upside constrained

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential recovery in steel demand and diversification into machinery could improve earnings
  • Debt burden and thin margins remain structural challenges
  • Dividend income provides a buffer while valuation remains above DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth-1.90%
Profit Margin3.85%
P/E Ratio8.2
ROE7.62%
ROA2.59%
Debt/Equity57.87
P/B Ratio0.6
Op. Cash Flow¥201.7B
Free Cash Flow¥72.3B

Technical Analysis

TrendNeutral
RSI51.5
Support¥1,857.00
Resistance¥2,018.50
MA 20¥1,935.33
MA 50¥1,934.93
MA 200¥1,967.46
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Fair Value¥917.24
Target Price¥2,031.43
Upside/Downside4.34%
GradeOvervalued
TypeValue
Dividend Yield4.21%

Risk Assessment

Beta0.49
Volatility27.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.